FDA to redo key compounding pharmacy policy in win for industry By Nate Raymond FDA plans to go through formal rule making process to redo and implement the MOU. Will not enforce 5% rule in meantime. But the federal legislation with the 5% cap is still the law on the books passed by Congress.

 

https://www.reuters.com/legal/litigation/fda-redo-key-compounding-pharmacy-policy-win-industry-2022-02-23/